Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Invasive Aspergillosis in Chronic Lymphocytic Leukemia: Therapy and Outcomes

Narjust Duma, MD, Jonas Paludo, MD, Brian Kabat, B.S., Aaron Tande, MD, Kari G Chaffee, MS, Timothy G. Call, MD, Saad Sirop Kenderian, MD, Wei Ding, MD PhD, Jose F. Leis, MD PhD, Melissa C. Larson, M.S., Asher A. Chanan-Khan, MD, Michael Conte, PA-C, Susan Marie Schwager, Susan L Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2017) 130 (Supplement 1): 4327.

https://doi.org/10.1182/blood.V130.Suppl_1.4327.4327

Published: 2017

Journal Articles

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Center

Paul J. Hampel, MD, Melissa C. Larson, M.S., Brian Kabat, B.S., Timothy G. Call, MD, Wei Ding, MD PhD, Saad Sirop Kenderian, MD, Michael Conte, PA-C, Susan Marie Schwager, Jose F. Leis, MD PhD, Asher A. Chanan-Khan, MD, Susan L Slager, PhD, Neil E. Kay, MD, Kari G Chaffee, MS, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2017) 130 (Supplement 1): 3023.

https://doi.org/10.1182/blood.V130.Suppl_1.3023.3023

Published: 2017

Journal Articles

Baseline Immune Dysregulation in Autologous Stem Cell Transplant Recipients Is Associated with a 'Graft Versus Host'-like Syndrome and Results in Poor Outcomes

Theodora Anagnostou, MD, Mrinal M. Patnaik, MDMBBS, Cynthia L Forsman, PhD, Reona Sakemura, MD PhD, Mark R. Litzow, MD, Dennis A. Gastineau, MD, Francis K Buadi, MD, Luis Porrata, MD, Julia S Lehman, MD, William J. Hogan, MBBCh, Shahrukh K. Hashmi, MDMPH, Saad Sirop Kenderian, MD

Blood (2017) 130 (Supplement 1): 4550.

https://doi.org/10.1182/blood.V130.Suppl_1.4550.4550

Published: 2017

Journal Articles

A Novel Prognostic Model To Predict Relapse After Allogeneic Stem Cell Transplantation For Myelodysplastic Syndromes

Saad Sirop Kenderian, MD, Mark R Litzow, MD, Aref Al-Kali, MD, Dennis A Gastineau, MD, Shahrukh K Hashmi, MD, William J Hogan, MD, Mrinal M Patnaik, MD

Blood (2013) 122 (21): 2098.

https://doi.org/10.1182/blood.V122.21.2098.2098

Published: 2013

Journal Articles

Chronic Graft Vs Host Disease Is The Strongest Predictor Of Outcome After Reduced Intensity Conditioning Stem Cell Transplantation In Chronic Lymphocytic Leukemia and Is Associated With Pretransplant B Cell Characteristics

Saad Sirop Kenderian, MD, Ruchi G. Sharma, Mrinal M Patnaik, MD, Timothy G. Call, MD, Shahrukh K Hashmi, MD, Neil E. Kay, MD, Wei Ding, MD, PhD, Mark R. Litzow, MD, Kari G. Rabe, MS, William Hogan, MD, Tait D. Shanafelt, M.D.

Blood (2013) 122 (21): 3375.

https://doi.org/10.1182/blood.V122.21.3375.3375

Published: 2013

NARROW

Invasive Aspergillosis in Chronic Lymphocytic Leukemia: Therapy and Outcomes

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Center

Baseline Immune Dysregulation in Autologous Stem Cell Transplant Recipients Is Associated with a 'Graft Versus Host'-like Syndrome and Results in Poor Outcomes

A Novel Prognostic Model To Predict Relapse After Allogeneic Stem Cell Transplantation For Myelodysplastic Syndromes

Chronic Graft Vs Host Disease Is The Strongest Predictor Of Outcome After Reduced Intensity Conditioning Stem Cell Transplantation In Chronic Lymphocytic Leukemia and Is Associated With Pretransplant B Cell Characteristics

Email alerts

ASH Publications

American Society of Hematology

Invasive Aspergillosis in Chronic Lymphocytic Leukemia: Therapy and Outcomes

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Center

Baseline Immune Dysregulation in Autologous Stem Cell Transplant Recipients Is Associated with a 'Graft Versus Host'-like Syndrome and Results in Poor Outcomes

A Novel Prognostic Model To Predict Relapse After Allogeneic Stem Cell Transplantation For Myelodysplastic Syndromes

Chronic Graft Vs Host Disease Is The Strongest Predictor Of Outcome After Reduced Intensity Conditioning Stem Cell Transplantation In Chronic Lymphocytic Leukemia and Is Associated With Pretransplant B Cell Characteristics

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only